Who
Gabriel Leung
Director
Company insider
Files Form 4 as: Director, NovoCure; Director, Pernix Therapeutics Holdings; Director, Albany Molecular Research; Director, Delcath Systems; EVP & Pres. Pharma. Business, Osi Pharmaceuticals.
In numbers
- Trades disclosed
- 258
- Buys
- 3
- Sells
- 46
- Bought
- $31K
- Sold
- $28.4M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 13 Jun 2006
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 2 Jun 2026filed 3 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $46K2,945 at $15.77 | filing |
| 2 Jun 2026filed 3 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $46K2,945 at $15.77 | filing |
| 4 Jun 2025filed 6 Jun 2025 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,697 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,215 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $17K999 at $17.31 | filing |
| 5 Jun 2024filed 6 Jun 2024 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,229 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —4,053 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $23K964 at $23.89 | filing |
| 7 Jun 2023filed 9 Jun 2023 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,277 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —3,853 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,350 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —2,427 at $0.00 | filing |
| 5 Aug 2021filed 6 Aug 2021 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 5 Aug 2021filed 6 Aug 2021 | NVCR NovoCureMedical Devices | SEC FORM 4 Code M | $31K1,000 at $31.45 | filing |
| 5 Aug 2021filed 6 Aug 2021 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $153K1,000 at $152.50 | filing |
| 6 Jul 2021filed 8 Jul 2021 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
News
Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NVCR · tickerreport.com · 15 Oct 2026NovoCure (NASDAQ:NVCR) and Medline (NASDAQ:MDLN) Financial AnalysisNVCR · themarketsdaily.com · 8 Oct 2026NovoCure (NASDAQ:NVCR) versus Kewaunee Scientific (NASDAQ:KEQU) Head-To-Head ReviewNVCR · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Gabriel Leung; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.